Alan K. Faraj
Uppsala, C, Sweden
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 14 publications
Pharmacokinetics and Safety of a Novel Clofazimine Formulation and Dosing Strategy in Children With Rifampicin-resistant Tuberculosis.
Journal: The Journal of infectious diseases
Published: March 20, 2026
A noninvasive BCG skin challenge model for assessing tuberculosis vaccine efficacy.
Journal: PLoS biology
Published: October 24, 2023
Subcutaneous Marzeptacog Alfa (Activated) for On-Demand Treatment of Bleeding Events in Subjects With Hemophilia A or B With Inhibitors.
Journal: Clinical pharmacology and therapeutics
Published: October 14, 2023
Cough as Noninvasive Biomarker for Monitoring Tuberculosis Treatment: A Proof-of-Concept Study.
Journal: Annals of the American Thoracic Society
Published: September 26, 2023
Model-Informed Support of Dose Selection for Prophylactic Treatment with Dalcinonacog Alfa in Adult and Paediatric Hemophilia B Patients.
Journal: Advances in therapy
Published: May 02, 2023
Standards for model-based early bactericidal activity analysis and sample size determination in tuberculosis drug development.
Journal: Frontiers in pharmacology
Published: January 23, 2023
Model-informed pediatric dose selection of marzeptacog alfa (activated): An exposure matching strategy.
Journal: CPT: pharmacometrics & systems pharmacology
Published: October 16, 2022
Phase III dose selection of marzeptacog alfa (activated) informed by population pharmacokinetic modeling: A novel hemostatic drug.
Journal: CPT: pharmacometrics & systems pharmacology
Published: June 02, 2022
Early Bactericidal Activity of Meropenem plus Clavulanate (with or without Rifampin) for Tuberculosis: The COMRADE Randomized, Phase 2A Clinical Trial.
Journal: American journal of respiratory and critical care medicine
Published: March 08, 2022
Difference in persistent tuberculosis bacteria between in vitro and sputum from patients: implications for translational predictions.
Journal: Scientific reports
Published: June 05, 2020
A model-based analysis identifies differences in phenotypic resistance between in vitro and in vivo: implications for translational medicine within tuberculosis.
Journal: Journal of pharmacokinetics and pharmacodynamics
Published: December 06, 2019
Drug Effect of Clofazimine on Persisters Explains an Unexpected Increase in Bacterial Load in Patients.
Journal: Antimicrobial agents and chemotherapy
Published: September 18, 2019
Last Updated: 09/26/2026